Publications

1. Ketha S, Smithedajkul P, Vella A, Pruthi R, Wysokinski W, McBane R. Adrenal haemorrhage due to heparin-induced thrombocytopenia. Thromb Haemost. 2013 Apr 8; 109(4):669-75. Epub 2013 Feb 07. 2302506
   View PubMed
2. Sathananthan M, Farrugia LP, Miles JM, Piccinini F, Man CD, Zinsmeister AR, Cobelli C, Rizza RA, Vella A. Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, beta-Cell Function and Glucose Metabolism in Non-Diabetic Subjects. Diabetes. 2013 Apr 01. [Epub ahead of print] 2314157
   View PubMed
3. Smushkin G, Sathananthan M, Piccinini F, Dalla Man C, Law JH, Cobelli C, Zinsmeister AR, Rizza RA, Vella A. The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes. Diabetes. 2013 Apr; 62(4):1094-101. Epub 2012 Dec 18. 2312004
   View PubMed
4. Donegan DM, Vella A. 69-year-old man with recurrent episodes of confusion and diaphoresis. Mayo Clin Proc. 2013 Apr; 88(4):410-3. 2314174
   View PubMed
5. Shin A, Camilleri M, Busciglio I, Burton D, Stoner E, Noonan P, Gottesdiener K, Smith SA, Vella A, Zinsmeister AR. Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics. Diabetes Care. 2013 Jan; 36(1):41-8. Epub 2012 Sep 06. 2269142
   View PubMed
6. Vella A. Enteroendocrine secretion after Roux-en-Y gastric bypass: is it important? Neurogastroenterol Motil. 2013 Jan; 25(1):1-3. 2292863
   View PubMed
7. Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB III, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The diabetes surgery study randomized clinical trial. JAMA. 2013; 309(21):2240-9. 2329819
   
8. Vella A, Kumar R. Osteocalcin and the regulation of glucose metabolism. Clinical Reviews in Bone and Mineral Metabolism. 2013; 11(1):11-6. 2313444
   
9. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, Carter RE, Melton LJ, Andersen H, Albers JW, Bolton CF, England JD, Klein CJ, Llewelyn G, Mauermann ML, Russell JW, Selvarajah D, Singer W, Smith AG, Tesfaye S, Vella A. "Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy: Cl vs N Phys Trial. Arch Neurol. 2012 Dec; 69(12):1609-14. 2271407
   View PubMed
10. Smushkin G, Sathananthan M, Sathananthan A, Dalla Man C, Micheletto F, Zinsmeister AR, Cobelli C, Vella A. Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1. Diabetes. 2012 May; 61(5):1082-9. Epub 2012 Mar 28. 2235456
    View PubMed
11. Erickson D, Singh RJ, Sathananthan A, Vella A, Bryant SC. Late-night salivary cortisol for diagnosis of Cushing's syndrome by liquid chromatography/tandem mass spectrometry assay. Clin Endocrinol (Oxf). 2012 Apr; 76(4):467-72. 2197054
    View PubMed
12. Vella A, Zinsmeister AR. Predicting diabetes using measures of beta-cell function. Diabetes. 2012 Mar; 61(3):562-3. 2235372
    View PubMed
13. Smushkin G, Sathananthan A, Man CD, Zinsmeister AR, Camilleri M, Cobelli C, Rizza RA, Vella A. Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes. J Clin Endocrinol Metab. 2012 Feb; 97(2):589-98. Epub 2011 Nov 16. 2222926
    View PubMed
14. Sathananthan A, Dalla Man C, Zinsmeister AR, Camilleri M, Rodeheffer RJ, Toffolo G, Cobelli C, Rizza RA, Vella A. A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. Clin Endocrinol (Oxf). 2012 Feb; 76(2):212-9. 2226591
    View PubMed
15. Levy MJ, Thompson GB, Topazian MD, Callstrom MR, Grant CS, Vella A. US-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest Endosc. 2012 Jan; 75(1):200-6. Epub 2011 Nov 10. 2206657
    View PubMed
16. Singh E, Vella A. Hypoglycemia after gastric bypass surgery. Diabetes Spectrum. 2012; 25(4):217-21. 2258601
    
17. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity. Neurogastroenterol Motil. 2011 Jul; 23(7):637-e257. Epub 2011 Apr 07. 2157422
    View PubMed
18. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of TCF7L2 allelic variations with gastric function, satiation, and GLP-1 levels. Clin Transl Sci. 2011 Jun; 4(3):183-7. 2173479
    View PubMed
19. Kumar R, Vella A. Carbohydrate metabolism and the skeleton: picking a bone with the beta-cell. J Clin Endocrinol Metab. 2011 May; 96(5):1269-71. Epub 2011 Feb 23. 2151588
    View PubMed
20. Richards ML, Thompson GB, Farley DR, Kendrick ML, Service JF, Vella A, Grant CS. Setting the bar for laparoscopic resection of sporadic insulinoma. World J Surg. 2011 Apr; 35(4):785-9. 2147330
    View PubMed
21. Kumar R, Binkley N, Vella A. Effect of phylloquinone supplementation on glucose homeostasis in humans. Am J Clin Nutr. 2010 Dec; 92(6):1528-32. Epub 2010 Sep 29. 2118624
    View PubMed
22. Vanderveen KA, Grant CS, Thompson GB, Farley DR, Richards ML, Vella A, Vollrath B, Service FJ. Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease. Surgery. 2010 Dec; 148(6):1237-45; discussion 1245-6. 1994852
    View PubMed
23. Smushkin G, Vella A. What is type 2 diabetes? Medicine (Abingdon). 2010 Nov 1; 38(11):597-601. 2136110
    View PubMed
24. Benavente-Chenhalls LA, Vella A, Farley DR, Thompson GB, Grant CS, Richards ML. Malignant adrenal neoplasm masquerading as worrisome adrenal hemorrhage. Ann Surg Oncol. 2010 Oct; 17(10):2710-3. Epub 2010 May 25. 2002072
    View PubMed
25. Sathananthan A, Man CD, Micheletto F, Zinsmeister AR, Camilleri M, Giesler PD, Laugen JM, Toffolo G, Rizza RA, Cobelli C, Vella A. Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study. Diabetes Care. 2010 Sep; 33(9):2074-6. 2114934
    View PubMed
26. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJ, O'Brien PC, Cl vs. NPhys Trial Investigators, Albers JW, Andersen H, Bolton CF, England JD, Klein CJ, Llewelyn JG, Mauermann ML, Russell JW, Singer W, Smith AG, Tesfaye S, Vella A. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve. 2010 Aug; 42(2):157-64. 2115577
    View PubMed
27. Bock G, Dalla Man C, Micheletto F, Basu R, Giesler PD, Laugen J, Deacon CF, Holst JJ, Toffolo G, Cobelli C, Rizza RA, Vella A. The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose. Clin Endocrinol (Oxf). 2010 Aug; 73(2):189-96. Epub 2009 Dec 18. 2109378
    View PubMed
28. Vella A. Common genetic variation influences the heterogeneity of response to oral glucose. Curr Diab Rep. 2010 Aug; 10(4):249-51. 1997711
    View PubMed
29. Smushkin G, Vella A. Genetics of type 2 diabetes. Curr Opin Clin Nutr Metab Care. 2010 Jul; 13(4):471-7. 2002152
    View PubMed
30. Dalla Man C, Micheletto F, Sathananthan A, Rizza RA, Vella A, Cobelli C. A model of GLP-1 action on insulin secretion in nondiabetic subjects. Am J Physiol Endocrinol Metab. 2010 Jun; 298(6):E1115-21. Epub 2010 Feb 23. 1954336
    View PubMed
31. Erickson D, Erickson B, Watson R, Patton A, Atkinson J, Meyer F, Nippoldt T, Carpenter P, Natt N, Vella A, Thapa P. 3 Tesla magnetic resonance imaging with and without corticotropin releasing hormone stimulation for the detection of microadenomas in Cushing's syndrome. Clin Endocrinol (Oxf). 2010 Jun; 72(6):793-9. Epub 2009 Oct 07. 1966684
    View PubMed
32. Papathanasopoulos A, Camilleri M, Carlson PJ, Vella A, Nord SJ, Burton DD, Odunsi ST, Zinsmeister AR. A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity. Obesity (Silver Spring). 2010 Jun; 18(6):1201-11. Epub 2009 Oct 29. 1970504
    View PubMed
33. Vella A, Rizza RA. Application of isotopic techniques using constant specific activity or enrichment to the study of carbohydrate metabolism. Diabetes. 2009 Oct; 58(10):2168-74. 1965317
    View PubMed
34. Samsom M, Bharucha A, Gerich JE, Herrmann K, Limmer J, Linke R, Maggs D, Schirra J, Vella A, Worle HJ, Goke B. Diabetes mellitus and gastric emptying: questions and issues in clinical practice. Diabetes Metab Res Rev. 2009 Sep; 25(6):502-14. 1978988
    View PubMed
35. Sathananthan A, Vella A. Personalized pharmacotherapy for Type 2 diabetes mellitus. Per Med. 2009 Jul 1; 6(4):417-422. 1965777
    View PubMed
36. Vella A. Pharmacogenetics for type 2 diabetes: practical considerations for study design. J Diabetes Sci Technol. 2009 Jul; 3(4):705-9. Epub 2009 Jul 01. 1986060
    View PubMed
37. Brown DL, Henrichsen TL, Clayton AC, Hudson SB, Coddington CC 3rd, Vella A. Ovarian stromal hyperthecosis: sonographic features and histologic associations. J Ultrasound Med. 2009 May; 28(5):587-93. 1938392
    View PubMed
38. Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, Andrews JC, Lloyd RV, Service FJ. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009 Apr; 94(4):1069-73. Epub 2009 Jan 13. 1921519
    View PubMed
39. Rumilla KM, Erickson LA, Service FJ, Vella A, Thompson GB, Grant CS, Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression. Mod Pathol. 2009 Feb; 22(2):239-45. Epub 2008 Oct 17. 1915505
    View PubMed
40. Dalla Man C, Bock G, Giesler PD, Serra DB, Ligueros-Saylan M, Foley JE, Camilleri M, Toffolo G, Cobelli C, Rizza RA, Vella A. The effect of Dipeptidyl Peptidase 4 Inhibition on Insulin Secretion and Action in Type 2 Diabetes. Diabetes Care. Jan. 2009; 1(14-8). 1913548
    
41. Dalla Man C, Bock G, Giesler PD, Serra DB, Ligueros Saylan M, Foley JE, Camilleri M, Toffolo G, Cobelli C, Rizza RA, Vella A. Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes. Diabetes Care. 2009 Jan; 32(1):14-8. Epub 2008 Oct 17. 1933366
    View PubMed
42. Arruda-Olson AM, Patch RK 3rd, Leibson CL, Vella A, Frye RL, Weston SA, Killian JM, Roger VL. Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction. Mayo Clin Proc. 2009; 84(1):28-33. 1920654
    View PubMed
43. Smushkin G, Vella A. Inhibition of dipeptidyl peptidase-4: The mechanisms of action and clinical use of vildagliptin for the management of type 2 diabetes. Diabetes Metab Syndr Obes. 2009; 2:83-90. Epub 2009 Jun 12. 2155529
    View PubMed
44. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Deacon CF, Foley JE, Rizza RA, Camilleri M. The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study. Clin Endocrinol (Oxf). 2008 Nov; 69(5):737-44. Epub 2008 Mar 10. 1915926
    View PubMed
45. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Vella A, Rocca WA, Petersen RC. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol. 2008 Aug; 65(8):1066-73. 1898837
    View PubMed
46. Szarka LA, Camilleri M, Vella A, Burton D, Baxter K, Simonson J, Zinsmeister AR. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol. 2008 Jun; 6(6):635-643.e1. Epub 2008 Apr 14. 1892687
    View PubMed
47. Porterfield JR, Thompson GB, Young WF Jr, Chow JT, Fryrear RS, van Heerden JA, Farley DR, Atkinson JL, Meyer FB, Abboud CF, Nippoldt TB, Natt N, Erickson D, Vella A, Carpenter PC, Richards M, Carney JA, Larson D, Schleck C, Churchward M, Grant CS. Surgery for Cushing's syndrome: an historical review and recent ten-year experience. World J Surg. 2008 May; 32(5):659-77. 1902476
    View PubMed
48. Young WF Jr, du Plessis H, Thompson GB, Grant CS, Farley DR, Richards ML, Erickson D, Vella A, Stanson AW, Carney JA, Abboud CF, Carpenter PC. The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World J Surg. 2008 May; 32(5):856-62. 1902477
    View PubMed
49. Vella A, Bouatia-Naji N, Heude B, Cooper JD, Lowe CE, Petry C, Ring SM, Dunger DB, Todd JA, Ong KK. Association analysis of the IGF1 gene with childhood growth, IGF-1 concentrations and type 1 diabetes. Diabetologia. 2008 May; 51(5):811-5. Epub 2008 Mar 04. 1913545
    View PubMed
50. Atkinson JL, Young WF Jr, Meyer FB, Davis DH, Nippoldt TB, Erickson D, Vella A, Natt N, Abboud CF, Carpenter PC. Sublabial transseptal vs transnasal combined endoscopic microsurgery in patients with Cushing disease and MRI-depicted microadenomas. Mayo Clin Proc. 2008 May; 83(5):550-3. 1885173
    View PubMed
51. Vella A, Camilleri M. Pharmacogenetics: potential role in the treatment of diabetes and obesity. Expert Opin Pharmacother. 2008 May; 9(7):1109-19. 1877177
    View PubMed
52. Vella A. Review: incretin therapy improves glycemic control more than placebo in patients with type 2 diabetes. ACP J Club. 2008 Jan-Feb; 148(1):3. 1915968
    View PubMed
53. Cooper JD, Smyth DJ, Bailey R, Payne F, Downes K, Godfrey LM, Masters J, Zeitels LR, Vella A, Walker NM, Todd JA. The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes - art. no. 71. BMC Medical Genetics. 2007 Nov 28; 8:71. 1898751
    View PubMed
54. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, Lowe CE, Szeszko JS, Hafler JP, Zeitels L, Yang JH, Vella A, Nutland S, Stevens HE, Schuilenburg H, Coleman G, Maisuria M, Meadows W, Smink LJ, Healy B Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007 Jul; 39(7):857-64 Epub 2007 Jun 6. 1931581
    View PubMed
55. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Dunning BE, Foley JE, Rizza RA, Camilleri M. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes. Diabetes. 2007 May; 56(5):1475-80. Epub 2007 Feb 15. 1824576
    View PubMed
56. Dingli D, Wolf RC, Vella A. Imatinib and type 2 diabetes. Endocr Pract. 2007 Mar-Apr; 13(2):126-30. 1828161
    View PubMed
57. Cooper JD, Smyth DJ, Bailey R, Payne F, Downes K, Godfrey LM, Masters J, Zeitels LR, Vella A, Walker NM, Todd JA. The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med Genet. 2007; 8. 1975642
    View PubMed
58. Ortu M, Vaccarezza M, Trovati S, Galli M, Gervasoni C, Vella A. A martial arts injury: karate induced unilateral haematoma of the adrenal gland. Br J Sports Med. 2006 Aug; 40(8):730-1; discussion 731. Epub 2006 May 24. 1968842
    View PubMed
59. Morris GA, Lowe CE, Cooper JD, Payne F, Vella A, Godfrey L, Hulme JS, Walker NM, Healy BC, Lam AC, Lyons PA, Todd JA. Polymorphism discovery and association analyses of the interferon genes in type 1 diabetes. BMC Genet. 2006; 7:12. Epub 2006 Feb 22. 1788604
    View PubMed
60. Smyth DJ, Howson JM, Payne F, Maier LM, Bailey R, Holland K, Lowe CE, Cooper JD, Hulme JS, Vella A, Dahlman I, Lam AC, Nutland S, Walker NM, Twells RC, Todd JA. Analysis of polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases. BMC Med Genet. 2006; 7:20. Epub 2006 Mar 06. 1788605
    View PubMed
61. Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring SM, McArdle W, Pembrey ME, Strachan DP, Dunger DB, Twells RC, Clayton DG, Todd JA. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet. 2005 May; 76(5):773-9. 1788603
    
62. Stewart CE, Vella A. Acarbose in liver cirrhosis: cognitive or glycemic control? Clin Gastroenterol Hepatol. 2005 Feb; 3(2):108-9. 1913404
    
63. Maier LM, Smyth DJ, Vella A, Payne F, Cooper JD, Pask R, Lowe C, Hulme J, Smink LJ, Fraser H, Moule C, Hunter KM, Chamberlain G, Walker N, Nutland S, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Strachan DP, Peterson LB, Todd JA, Construction and analysis of tag single nucleotide polymorphism maps for six human-mouse orthologous candidate genes in type 1 diabetes. BMC Genet. 2005; 6(1):9. Epub 2005 Feb 18. 1788600
    View PubMed
64. Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA, Howson JM, Vella A, Nutland S, Rance HE, Maier L, Barratt BJ, Guja C, Ionescu-Tirgoviste C, Savage DA, Dunger DB, Widmer B, Strachan DP, Ring SM, Walker N, Clayton DG, Twells RC, Gough SC, Todd JA. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes. 2004 Nov; 53(11):3020-3. 1788596
    View PubMed
65. Vella A, Rizza RA. Extrapancreatic effects of GIP and GLP-1. Horm Metab Res. 2004 Nov-Dec; 36(11-12):830-6. 1680705
    View PubMed
66. Vella A, Camilleri M, Rizza RA. The gastrointestinal tract and glucose tolerance. Curr Opin Clin Nutr Metab Care. 2004 Jul; 7(4):479-84. 1653752
    View PubMed
67. Vella A, Howson JM, Barratt BJ, Twells RC, Rance HE, Nutland S, Tuomilehto-Wolf E, Tuomilehto J, Undlien DE, Ronningen KS, Guja C, Ionescu-Tirgoviste C, Savage DA, Todd JA. Lack of association of the Ala(45)Thr polymorphism and other common variants of the NeuroD gene with type 1 diabetes. Diabetes. 2004 Apr; 54(4):1158-61. 1788592
    
68. Reed AS, Charkoudian N, Vella A, Shah P, Rizza RA, Joyner MJ. Forearm vascular control during acute hyperglycemia in healthy humans. Am J Physiol Endocrinol Metab. 2004 Mar; 286(3):E472-80. Epub 2003 Oct 28. 1639070
    View PubMed
69. Eftychi C, Howson JM, Barratt BJ, Vella A, Payne F, Smyth DJ, Twells RC, Walker NM, Rance HE, Tuomilehto-Wolf E, Tuomilehto J, Undlien DE, Ronningen KS, Guja C, Ionescu-Tiirgoviste C, Savage DA, Todd JA. Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes. Diabetes. 2004 Mar; 53(3):870-3. 1788588
    View PubMed
70. Adkins A, Basu R, Persson M, Dicke B, Shah P, Vella A, Schwenk WF, Rizza R. Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. Diabetes. 2003 Sep; 52(9):2213-20. 1413610
    View PubMed
71. Delgado-Aros S, Vella A, Camilleri M, Low PA, Burton DD, Thomforde GM, Stephens D. Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil. 2003 Aug; 15(4):435-43. 1404986
    View PubMed
72. Vella A, Reed AS, Charkoudian N, Shah P, Basu R, Basu A, Joyner MJ, Rizza RA. Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles. Am J Physiol Endocrinol Metab. 2003 Jul; 285(1):E25-30. Epub 2003 Mar 11. 1404247
    View PubMed
73. Vella A, Service FJ, O'Brien PC. Glucose counterregulatory hormones in the 72-hour fast. Endocr Pract. 2003 Mar-Apr; 9(2):115-8. 1644130
    View PubMed
74. Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA. Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes. 2003 Jan; 52(1):38-42. 1317988
    View PubMed
75. Basu R, Di Camillo B, Toffolo G, Basu A, Shah P, Vella A, Rizza R, Cobelli C. Use of a novel triple-tracer approach to assess postprandial glucose metabolism. Am J Physiol Endocrinol Metab. 2003 Jan; 284(1):E55-69. 1317919
    View PubMed
76. Kurtkaya-Yapicier O, Scheithauer BW, Carney JA, Kovacs K, Horvath E, Stratakis CA, Vidal S, Vella A, Young WF Jr, Atkinson JL, Lloyd RV, Kontogeorgos G. Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic study. Ultrastruct Pathol. 2002 Nov-Dec; 26(6):345-53. 1317847
    View PubMed
77. Vella A, Shah P, Reed AS, Adkins AS, Basu R, Rizza RA. Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans. Diabetologia. 2002 Oct; 45(10):1410-5. Epub 2002 Sep 05. 1316997
    View PubMed
78. Charkoudian N, Vella A, Reed AS, Minson CT, Shah P, Rizza RA, Joyner MJ. Cutaneous vascular function during acute hyperglycemia in healthy young adults. J Appl Physiol. 2002 Oct; 93(4):1243-50. 1316186
    View PubMed
79. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E259-66. 1314813
    View PubMed
80. Vella A, Lee JS, Camilleri M, Szarka LA, Burton DD, Zinsmeister AR, Rizza RA, Klein PD. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil. 2002 Apr; 14(2):123-31. 1315542
    View PubMed
81. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol. 2002 Mar; 282(3):G424-31. 1008422
    View PubMed
82. Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA. Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes. 2002 Feb; 51(2):301-10. 1008071
    View PubMed
83. Vella A, Pineda AA, O'Brien T. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia. Mayo Clin Proc. 2001 Oct; 76(10):1039-46. 1005132
    View PubMed
84. Vella A, Young WF. Pituitary apoplexy. Endocrinologist. 2001 Jul-Aug; 11(4):282-8. 1004031
    View PubMed
85. Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD. Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab. 2001 Jun; 280(6):E1000-6. 1005026
    View PubMed
86. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, Nair KS, Schwenk WF, Rizza RA. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding: additional evidence for a defect in hepatic glucokinase activity. Diabetes. 2001 Jun; 50(6):1351-62. 1005094
    View PubMed
87. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia. 2001 Jun; 44(6):729-37. 1004513
    View PubMed
88. Vella A, Thompson GB, Grant CS, van Heerden JA, Farley DR, Young WF Jr. Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab. 2001 Apr; 86(4):1596-9. 1004198
    View PubMed
89. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes. 2001 Mar; 50(3):565-72. 1003674
    View PubMed
90. Vella A, Nippoldt TB, Morris JC 3rd. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc. 2001 Feb; 76(2):161-8. 1003599
    View PubMed
91. Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2000 Nov; 85(11):4053-9. 1014052
    View PubMed
92. Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol. 2000 Jun; 278(6):G946-51. 134150
    View PubMed
93. Vella A, Shah P, Basu R, Basu A, Holst JJ, Rizza RA. Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes. Diabetes. 2000 Apr; 49(4):611-7. 131603
    View PubMed
94. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA. Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes. 2000 Feb; 49(2):272-83. 128316
    View PubMed
95. Vella A, Carlson LA, Blier B, Felty C, Kuiper JD, Rooke TW. Circulator boot therapy alters the natural history of ischemic limb ulceration. Vasc Med. 2000; 5(1):21-5. 1012282
    View PubMed
96. Vella A, Gerber TC, Hayes DL, Reeder GS. Digoxin, hypercalcaemia, and cardiac conduction. Postgrad Med J. 1999 Sep; 75(887):554-6. 1009596
    View PubMed
97. Vella A, McPhail I, Litin S. Unilateral proptosis in a 74-year-old woman. Adv Exp Med Biol. 1999; 455:529-33. 1011115
    View PubMed
98. Vella A, Farrugia G. D-lactic acidosis: pathologic consequence of saprophytism. Mayo Clin Proc. 1998 May; 73(5):451-6. 104884
    View PubMed
99. Vella A, McPhail IR, Litin SC. 74-year-old woman with cough and proptosis. Mayo Clin Proc. 1997 Jun; 72(6):575-8. 98838
    View PubMed
100. Vella A, Farrugia G. 90-year-old man with fever and melena (translated into Polish). Medycyna Prakyczna. 1997 May. 1788574
     
101. Vella A, Farrugia G. 90-year-old man with fever and melena. Mayo Clin Proc. 1996 Dec; 71(12):1205-8. 98334
     View PubMed